相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A short history of heme dioxygenases: rise, fall and rise again
Emma L. Raven
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (ID01) Inhibitor for Immunooncology
Eddy W. Yue et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Structural insights into the binding mechanism of IDO1 with hydroxylamidine based inhibitor INCB14943
You Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
Yi-Hui Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Harnessing Fluorine-Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs
Matthias R. Bauer et al.
ACS CHEMICAL BIOLOGY (2016)
Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications
Lucia Alvarez et al.
BIOCHEMISTRY (2016)
Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase
Ariel Lewis-Ballester et al.
SCIENTIFIC REPORTS (2016)
Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Ute F. Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Tryptophan-degrading enzymes in tumoral immune resistance
Nicolas van Baren et al.
FRONTIERS IN IMMUNOLOGY (2015)
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
George C. Prendergast et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Crystal Structures and Structure Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors
Shingo Tojo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
How good are my data and what is the resolution?
Philip R. Evans et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Complete Reaction Mechanism of Indoleamine 2,3-Dioxygenase as Revealed by QM/MM Simulations
Luciana Capece et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Linking Crystallographic Model and Data Quality
P. Andrew Karplus et al.
SCIENCE (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Ferryl Derivatives of Human Indoleamine 2,3-Dioxygenase
Changyuan Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Spectroscopic Studies of Ligand and Substrate Binding to Human Indoleamine 2,3-Dioxygenase
Changyuan Lu et al.
BIOCHEMISTRY (2010)
The first step of the dioxygenation reaction carried out by tryptophan dioxygenase and indoleamine 2,3-dioxygenase as revealed by quantum mechanical/molecular mechanical studies
Luciana Capece et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
ONIOM Study on a Missing Piece in Our Understanding of Heme Chemistry: Bacterial Tryptophan 2,3-Dioxygenase with Dual Oxidants
Lung Wa Chung et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase
Changyuan Lu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Evidence for a ferryl intermediate in a heme-based dioxygenase
Ariel Lewis-Ballester et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Probing the Function of Heme Distortion in the H-NOX Family
Charles Olea et al.
ACS CHEMICAL BIOLOGY (2008)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Interactions between Nitric Oxide and Indoleamine 2,3-dioxygenase
Ben J. Samelson-Jones et al.
BIOCHEMISTRY (2006)
Crystal structure of human indoleamine 2,3-dioxygenase:: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase
H Sugimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Heme distortion modulated by ligand-protein interactions in inducible nitric-oxide synthase
D Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Ligand-induced heme ruffling and bent NO geometry in ultra-high-resolution structures of nitrophorin 4
SA Roberts et al.
BIOCHEMISTRY (2001)